Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Medically reviewed by Suzanne Fisher, RD If you’re one of the 85% of American adults who drink alcohol, whether occasionally ...

People with type 2 diabetes who stick to a low-carb diet may be able to stop taking medication, suggests a new study. American researchers found that low-carbohydrate diets may improve beta-cell ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Discover the latest findings from the CDC on the growing prevalence of adult diabetes in the US, including key factors such as age, weight and education levels.

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...